Klingman & Associates, LLC Abb Vie Inc. Transaction History

Klingman & Associates, LLC

$1.61 Billion
Q3 2024

A detailed history of Klingman & Associates, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Klingman & Associates, LLC holds 11,665 shares of ABBV stock, worth $1.99 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

11,665

Previous 8,596 35.7%

Holding current value

$1.99 Million

Previous $1.47 Million 56.24%

% of portfolio

0.14%

Previous 0.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$163.84 - $199.33 $502,824 - $611,743	3,069 Added 35.7%	11,665 $2.3 Million
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $47,056 - $54,951	304 Added 3.67%	8,596 $1.47 Million
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $5,913 - $6,737	37 Added 0.45%	8,292 $1.51 Million
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $2,064 - $2,324	15 Added 0.18%	8,255 $1.28 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $6,278 - $7,268	47 Added 0.57%	8,240 $1.23 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $27,429 - $34,134	207 Added 2.59%	8,193 $1.1 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $5,639 - $6,495	39 Added 0.49%	7,986 $1.27 Million
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $12,171 - $14,596	88 Added 1.12%	7,947 $1.29 Million
Q3 2022 Oct 28, 2022	BUY	$134.21 - $153.93 $671 - $769	5 Added 0.06%	7,859 $1.06 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $14,587 - $18,545	-106 Reduced 1.33%	7,854 $1.2 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $380,366 - $471,927	2,882 Added 56.75%	7,960 $1.29 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $7,197 - $9,107	67 Added 1.34%	5,078 $688,000
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $6,064 - $6,884	57 Added 1.15%	5,011 $541,000
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $8,101 - $9,025	77 Added 1.58%	4,954 $558,000
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $5,115 - $5,631	50 Added 1.04%	4,877 $528,000
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $89,088 - $104,560	1,037 Added 27.36%	4,827 $423,000
Q2 2019 Sep 27, 2019	BUY	$65.7 - $83.98 $249,003 - $318,284	3,790 New	3,790 $276,000
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $249,003 - $318,284	-3,790 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$77.14 - $90.79 $8,099 - $9,532	105 Added 2.85%	3,790 $305,000
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $9,516 - $11,260	-106 Reduced 2.8%	3,685 $341,000
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $9,753 - $13,060	106 Added 2.88%	3,791 $359,000
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $257,397 - $328,775	3,685	3,685 $327,000

Others Institutions Holding ABBV

# of Institutions

3,869

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingman & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klingman & Associates, LLC with notifications on news.

Account

Klingman & Associates, LLC Abb Vie Inc. Transaction History